You can Subscribe to our RSS FEED: which delivers brain tumor news and additions to the website via RSS.
Click HERE for details on RSS.
Displaying items 3101 to 3125 of about 5928
Next 25
02/11/2010
New Scientific Publication Highlights Long-Term Survival of Brain Cancer Patients Treated With Peregrine Pharmaceuticals` Cotara(R)
02/09/2010
"A Night of Hopes & Dreams" Gala to Support Local Pediatric Brain Tumor Foundation
Brain Tumor Awareness Postage Stamp
02/07/2010
State To Test Water, Soil In The Acreage
02/06/2010
UCLA Neuro-oncology 10th Annual Brain Tumor Conference
02/01/2010
Radiation Therapy Harms the Brain, Causing Memory and Attention Problems
01/30/2010
Scientists Decode Brain Cancer Cell Line
Lisa Kaminsky Millar
01/28/2010
New therapies improving survival in patients with glioblastoma
Living With a Brain Tumor - A Conference for Patients and Families in Washington, DC
Is there an advantage to administering bevacizumab directly to brain tumors using microcatheters?
01/26/2010
Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis
Magical Moon Foundation announces “A Knight to Remember” benefit dinner dance.
UPDATE 4-Teva wins patent battle over Merck`s Temodar
01/25/2010
New Study Shows ImmunoCellular Therapeutics` Lead Investigational Cancer Vaccine ICT-107 Targets Cancer Stem Cells
01/23/2010
Phase II trial of low-dose continuous (metronomic) treatment of temozolomide for recurrent glioblastoma
Boron Neutron Capture Therapy for glioblastoma multiforme: advantage of prolonged infusion of BPA-f.
A Cookbook For Kristine
Concerns about anti-angiogenic treatment in patients with glioblastoma multiforme.
01/21/2010
Why Brain Tumors Render Drugs Useless - Scientists evidence a new mechanism of action
01/17/2010
IBTA E-News January 2010
01/16/2010
Bevacizumab and dose-intense temozolomide in recurrent high-grade glioma.
01/13/2010
Brain Cancer: Searching for a Breakthrough with Cell & Gene Therapy Thursday, January 28, 2010 7:00 p.m. Bruce Museum, Greenwich, Connecticut
01/12/2010
Mutant metabolic enzymes are at the origin of gliomas.
Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme.